Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
China Traditional Chinese Medicine Holdings Co., headquartered in China, is a prominent player in the Pharmaceutical Preparation Manufacturing industry. Established in 2000, the company has made significant strides in the development and distribution of traditional Chinese medicine products, catering to both domestic and international markets.
With a focus on herbal formulations and innovative healthcare solutions, China Traditional Chinese Medicine Holdings Co. offers a unique range of products that blend ancient practices with modern manufacturing techniques. Their commitment to quality and efficacy has positioned them as a trusted name in the industry, achieving notable recognition for their contributions to holistic health.
The company continues to expand its operational footprint, enhancing its market presence through strategic partnerships and a robust distribution network, solidifying its status as a leader in the traditional medicine sector.
-1 vs industry average
China Traditional Chinese Medicine Holdings Co’s score of 41 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
China Traditional Chinese Medicine Holdings Co. (based in CN) reported approximately 237.6 million kg CO2e in combined Scope 1 and Scope 2 emissions for 2024. This includes about 104.4 million kg CO2e from Scope 1 and approximately 133.2 million kg CO2e from Scope 2.
In 2023, the Pharmaceutical Preparation Manufacturing company's combined Scope 1 and Scope 2 emissions were approximately 338.8 million kg CO2e, comprising about 106.6 million kg CO2e from Scope 1 and approximately 232.2 million kg CO2e from Scope 2. The company's combined Scope 1 and 2 emissions have shown a decrease from approximately 377.9 million kg CO2e in 2022.
The company has not disclosed Scope 3 emissions data. There are no publicly available specific reduction targets or climate pledges.
No climate goals have been disclosed for China Traditional Chinese Medicine Holdings Co yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more